Search NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Nasdaq · CIK 1500198
Last close1.12
Daily change+0.13 (13.71%)
10 Years gain-98.45%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
NMTC · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0930
Fundamental
70.1Momentum
34.8Acceleration
20.9Confidence
76.0Annual Revenue12
Quarterly Revenue38
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth24.0 / 25
Quality14.2 / 25
Capital Efficiency8.0 / 20
Balance Sheet13.4 / 15
Shareholder Economics7.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 6.1644 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Negative FCF · HIGHLatest free cash flow is negative.
Operating margin compression · MEDIUMOperating margin compressed by 3.0321 percentage points.
Heavy share dilution · HIGHDiluted share count increased 68.5512%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
ROIC declining · MEDIUMROIC declined by 277.7408 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM22.73%OK
Revenue CAGR 3Y275.98%OK
Gross Margin55.27%OK
Operating Margin-99.9%OK
FCF Margin-84.67%OK
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-467.23%OK
Incremental Operating Margin 3Y39.25%OK
Net Debt / CFO0.29xOK
Diluted Share Growth 1Y68.55%OK
SBC / Revenue16.27%OK
SBC / FCF-19.22%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | $9.10M | $5.14M | -$4.23M | -$2.84M | -$2.92M | 56.51% | -46.46% | -32.09% | n/a | 40.15M |
| 2025 FY Sep 30, 2024 | $3.45M | $1.08M | -$11.89M | -$11.01M | -$11.13M | 31.27% | -344.26% | -322.39% | -6,501.54% | 26.76M |
| 2024 FY Sep 30, 2023 | $1.95M | $456,517.00 | -$11.96M | -$12.89M | -$13.27M | 23.38% | -612.32% | -679.71% | n/a | 18.12M |
| 2023 FY Sep 30, 2022 | $171,169.00 | -$70,794.00 | -$10.03M | -$7.52M | -$7.79M | -41.36% | -5,860.15% | -4,553.84% | n/a | 16M |
| 2022 FY Sep 30, 2021 | $178,146.00 | -$97,749.00 | -$10.22M | -$8.60M | -$8.67M | -54.87% | -5,735.86% | -4,866.74% | n/a | 10.7M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $8.42M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-088724, 0001213900-26-016860 |
| Revenue Growth TTM | 22.73% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-088724, 0001213900-26-016860 |
| Revenue CAGR 3Y | 275.98% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-25-122390 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001213900-25-122390 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001213900-25-122390 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-088724, 0001213900-26-016860 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-088724, 0001213900-26-068307 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 55.27% | Gross Profit / Revenue | OK | 0001213900-26-088724, 0001213900-26-016860 |
| Operating Margin | -99.9% | Operating Income / Revenue | OK | 0001213900-26-088724, 0001213900-26-016860 |
| FCF Margin | -84.67% | (CFO - CapEx) / Revenue | OK | 0001213900-26-088724, 0001213900-26-068307 |
| ROIC | -467.23% | NOPAT / Average Invested Capital | OK | 0001213900-26-088724, 0001213900-26-016860 |
| Net Debt / CFO | 0.29x | Net Debt / CFO | OK | 0001213900-26-088724, 0001213900-26-068307 |
| Current Ratio | 2.84x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 16.27% | SBC / Revenue | OK | 0001213900-26-088724, 0001213900-26-068307 |